Pseudomonas aeruginosa global clones associated with multidrug-resistant (MDR) and
extensively drug-resistant (XDR) phenotypes, denominated high-risk clones, are a growing …

Worldwide, Pseudomonas aeruginosa remains a leading nosocomial pathogen that is
difficult to treat and constitutes a challenging menace to healthcare systems. P. aeruginosa …

Background ESBL-and carbapenemase-producing Pseudomonas aeruginosa are prevalent
in, for example, the Middle East, Eastern Europe and Latin America, though rarer elsewhere …

Animal-derived Enterobacteriaceae bacteria such as Escherichia coli (E. coli), Proteus
mirabilis (P. mirabilis), and Klebsiella pneumoniae (K. pneumoniae) are important food …

This nationwide study aimed to investigate the molecular characteristics of metallo-β-
lactamase (MBL)-producing Pseudomonas aeruginosa in Serbia, underlying resistance …

Carbapenem resistance is a major concern in the management of antibiotic-resistant
Pseudomonas aeruginosa infections. The direct prediction of carbapenem-resistant …

Introduction: The increasing incidence of infections caused by multidrug-resistant bacteria is
considered a global health problem. This study aimed to investigate this resistance in Gram …

The increasing integration of genomics into routine clinical diagnostics requires reliable
computational tools to identify determinants of antimicrobial resistance (AMR) from whole …

Abstract Objective Carbapenem-resistant Enterobacterales (CRE) infections result in higher
treatment costs and mortality rates. Integrons play important roles in emergence and spread …

Pseudomonas aeruginosa is the primary opportunistic human pathogen responsible for a
range of acute and chronic infections; it poses a significant threat to immunocompromised …